AU2002221702A1 - Pharmaceutical compositions - Google Patents
Pharmaceutical compositionsInfo
- Publication number
- AU2002221702A1 AU2002221702A1 AU2002221702A AU2170202A AU2002221702A1 AU 2002221702 A1 AU2002221702 A1 AU 2002221702A1 AU 2002221702 A AU2002221702 A AU 2002221702A AU 2170202 A AU2170202 A AU 2170202A AU 2002221702 A1 AU2002221702 A1 AU 2002221702A1
- Authority
- AU
- Australia
- Prior art keywords
- pharmaceutical compositions
- mum
- median
- particles
- clavulanic acid
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Abandoned
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D503/00—Heterocyclic compounds containing 4-oxa-1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula:, e.g. oxapenicillins, clavulanic acid derivatives; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulfur-containing hetero ring
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D503/00—Heterocyclic compounds containing 4-oxa-1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula:, e.g. oxapenicillins, clavulanic acid derivatives; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulfur-containing hetero ring
- C07D503/10—Heterocyclic compounds containing 4-oxa-1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula:, e.g. oxapenicillins, clavulanic acid derivatives; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulfur-containing hetero ring with a carbon atom having three bonds to hetero atoms with at the most one bond to halogen, e.g. an ester or nitrile radical, directly attached in position 2
- C07D503/12—Heterocyclic compounds containing 4-oxa-1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula:, e.g. oxapenicillins, clavulanic acid derivatives; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulfur-containing hetero ring with a carbon atom having three bonds to hetero atoms with at the most one bond to halogen, e.g. an ester or nitrile radical, directly attached in position 2 unsubstituted in position 6
- C07D503/14—Heterocyclic compounds containing 4-oxa-1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula:, e.g. oxapenicillins, clavulanic acid derivatives; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulfur-containing hetero ring with a carbon atom having three bonds to hetero atoms with at the most one bond to halogen, e.g. an ester or nitrile radical, directly attached in position 2 unsubstituted in position 6 with hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, other than a carbon atom having three bonds to hetero atoms with at the most one bond to halogen, attached in position 3
- C07D503/16—Radicals substituted by hetero atoms or by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. an ester or nitrile radical
- C07D503/18—Radicals substituted by hetero atoms or by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. an ester or nitrile radical by oxygen atoms
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Oncology (AREA)
- Communicable Diseases (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
- Medicinal Preparation (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
Abstract
Clavulanic acid, in which the median of the particles is from 8 mum to 35 mum and their use in pharmaceutical compositions.
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
AT18062000 | 2000-10-20 | ||
AT1806/2000 | 2000-10-20 | ||
PCT/EP2001/012076 WO2002032906A1 (en) | 2000-10-20 | 2001-10-18 | Pharmaceutical compositions |
Publications (1)
Publication Number | Publication Date |
---|---|
AU2002221702A1 true AU2002221702A1 (en) | 2002-04-29 |
Family
ID=3689001
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
AU2002221702A Abandoned AU2002221702A1 (en) | 2000-10-20 | 2001-10-18 | Pharmaceutical compositions |
Country Status (13)
Country | Link |
---|---|
US (1) | US20040043981A1 (en) |
EP (1) | EP1328528B1 (en) |
JP (2) | JP2004511561A (en) |
KR (1) | KR20030069995A (en) |
CN (1) | CN1267437C (en) |
AT (1) | ATE286057T1 (en) |
AU (1) | AU2002221702A1 (en) |
CA (1) | CA2424462C (en) |
DE (1) | DE60108154T2 (en) |
ES (1) | ES2234919T3 (en) |
MX (1) | MXPA03003312A (en) |
PL (1) | PL360254A1 (en) |
WO (1) | WO2002032906A1 (en) |
Families Citing this family (28)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US7295509B2 (en) | 2000-09-13 | 2007-11-13 | Qualcomm, Incorporated | Signaling method in an OFDM multiple access system |
US9130810B2 (en) | 2000-09-13 | 2015-09-08 | Qualcomm Incorporated | OFDM communications methods and apparatus |
US9246560B2 (en) | 2005-03-10 | 2016-01-26 | Qualcomm Incorporated | Systems and methods for beamforming and rate control in a multi-input multi-output communication systems |
US9154211B2 (en) | 2005-03-11 | 2015-10-06 | Qualcomm Incorporated | Systems and methods for beamforming feedback in multi antenna communication systems |
US8446892B2 (en) | 2005-03-16 | 2013-05-21 | Qualcomm Incorporated | Channel structures for a quasi-orthogonal multiple-access communication system |
US9143305B2 (en) | 2005-03-17 | 2015-09-22 | Qualcomm Incorporated | Pilot signal transmission for an orthogonal frequency division wireless communication system |
US9520972B2 (en) | 2005-03-17 | 2016-12-13 | Qualcomm Incorporated | Pilot signal transmission for an orthogonal frequency division wireless communication system |
US9184870B2 (en) | 2005-04-01 | 2015-11-10 | Qualcomm Incorporated | Systems and methods for control channel signaling |
US9036538B2 (en) | 2005-04-19 | 2015-05-19 | Qualcomm Incorporated | Frequency hopping design for single carrier FDMA systems |
US9408220B2 (en) | 2005-04-19 | 2016-08-02 | Qualcomm Incorporated | Channel quality reporting for adaptive sectorization |
US8879511B2 (en) | 2005-10-27 | 2014-11-04 | Qualcomm Incorporated | Assignment acknowledgement for a wireless communication system |
US8462859B2 (en) | 2005-06-01 | 2013-06-11 | Qualcomm Incorporated | Sphere decoding apparatus |
US8599945B2 (en) | 2005-06-16 | 2013-12-03 | Qualcomm Incorporated | Robust rank prediction for a MIMO system |
US9179319B2 (en) | 2005-06-16 | 2015-11-03 | Qualcomm Incorporated | Adaptive sectorization in cellular systems |
US8885628B2 (en) | 2005-08-08 | 2014-11-11 | Qualcomm Incorporated | Code division multiplexing in a single-carrier frequency division multiple access system |
US9209956B2 (en) | 2005-08-22 | 2015-12-08 | Qualcomm Incorporated | Segment sensitive scheduling |
US8644292B2 (en) | 2005-08-24 | 2014-02-04 | Qualcomm Incorporated | Varied transmission time intervals for wireless communication system |
US9136974B2 (en) | 2005-08-30 | 2015-09-15 | Qualcomm Incorporated | Precoding and SDMA support |
US9225488B2 (en) | 2005-10-27 | 2015-12-29 | Qualcomm Incorporated | Shared signaling channel |
US9225416B2 (en) | 2005-10-27 | 2015-12-29 | Qualcomm Incorporated | Varied signaling channels for a reverse link in a wireless communication system |
US8045512B2 (en) | 2005-10-27 | 2011-10-25 | Qualcomm Incorporated | Scalable frequency band operation in wireless communication systems |
US9210651B2 (en) | 2005-10-27 | 2015-12-08 | Qualcomm Incorporated | Method and apparatus for bootstraping information in a communication system |
US9088384B2 (en) | 2005-10-27 | 2015-07-21 | Qualcomm Incorporated | Pilot symbol transmission in wireless communication systems |
US8582509B2 (en) | 2005-10-27 | 2013-11-12 | Qualcomm Incorporated | Scalable frequency band operation in wireless communication systems |
US9144060B2 (en) | 2005-10-27 | 2015-09-22 | Qualcomm Incorporated | Resource allocation for shared signaling channels |
US8477684B2 (en) | 2005-10-27 | 2013-07-02 | Qualcomm Incorporated | Acknowledgement of control messages in a wireless communication system |
US8693405B2 (en) | 2005-10-27 | 2014-04-08 | Qualcomm Incorporated | SDMA resource management |
KR20120012823A (en) * | 2009-04-29 | 2012-02-10 | 렉산 파마슈티컬스, 인코포레이티드 | Clavulanate formulation for neuroprotection and treatment of neurodegenerative disorders |
Family Cites Families (8)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US29038A (en) * | 1860-07-03 | George a | ||
NZ189022A (en) * | 1977-12-08 | 1981-11-19 | Beecham Group Ltd | Pharmaceutically acceptable particles of clavulanates dispersed in a polymeric binder |
US5750685A (en) * | 1987-01-29 | 1998-05-12 | Smithkline Beecham, P.L.C. | Process for preparing potassium clavulanate in rossette form |
US5288861A (en) * | 1987-01-29 | 1994-02-22 | Beecham Group Plc | Potassium clavulanate in rosette form |
GB9109862D0 (en) * | 1991-05-08 | 1991-07-03 | Beecham Lab Sa | Pharmaceutical formulations |
AT403375B (en) * | 1995-11-15 | 1998-01-26 | Biochemie Gmbh | METHOD FOR FILLING ALKALINE SALTS OF CLAVULANIC ACID |
AT404728B (en) * | 1996-11-27 | 1999-02-25 | Biochemie Gmbh | METHOD FOR PRODUCING CLAVULIC ACID AMINE SALTS |
MXPA01009808A (en) * | 1999-04-01 | 2002-04-24 | Dsm Nv | Agglomerates by crystallisation. |
-
2001
- 2001-10-18 CA CA2424462A patent/CA2424462C/en not_active Expired - Lifetime
- 2001-10-18 AT AT01987751T patent/ATE286057T1/en active
- 2001-10-18 MX MXPA03003312A patent/MXPA03003312A/en active IP Right Grant
- 2001-10-18 WO PCT/EP2001/012076 patent/WO2002032906A1/en active IP Right Grant
- 2001-10-18 KR KR10-2003-7004308A patent/KR20030069995A/en active Search and Examination
- 2001-10-18 CN CNB018175538A patent/CN1267437C/en not_active Expired - Lifetime
- 2001-10-18 DE DE60108154T patent/DE60108154T2/en not_active Expired - Lifetime
- 2001-10-18 EP EP01987751A patent/EP1328528B1/en not_active Expired - Lifetime
- 2001-10-18 US US10/399,427 patent/US20040043981A1/en not_active Abandoned
- 2001-10-18 ES ES01987751T patent/ES2234919T3/en not_active Expired - Lifetime
- 2001-10-18 AU AU2002221702A patent/AU2002221702A1/en not_active Abandoned
- 2001-10-18 JP JP2002536287A patent/JP2004511561A/en active Pending
- 2001-10-18 PL PL01360254A patent/PL360254A1/en unknown
-
2009
- 2009-05-01 JP JP2009112262A patent/JP2009197020A/en active Pending
Also Published As
Publication number | Publication date |
---|---|
CN1469880A (en) | 2004-01-21 |
JP2004511561A (en) | 2004-04-15 |
US20040043981A1 (en) | 2004-03-04 |
KR20030069995A (en) | 2003-08-27 |
EP1328528A1 (en) | 2003-07-23 |
ATE286057T1 (en) | 2005-01-15 |
DE60108154D1 (en) | 2005-02-03 |
DE60108154T2 (en) | 2005-12-22 |
CN1267437C (en) | 2006-08-02 |
JP2009197020A (en) | 2009-09-03 |
PL360254A1 (en) | 2004-09-06 |
MXPA03003312A (en) | 2004-12-03 |
EP1328528B1 (en) | 2004-12-29 |
CA2424462A1 (en) | 2002-04-25 |
CA2424462C (en) | 2010-03-30 |
WO2002032906A1 (en) | 2002-04-25 |
ES2234919T3 (en) | 2005-07-01 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
AU2002221702A1 (en) | Pharmaceutical compositions | |
WO2001058412A3 (en) | Extracts from residues left in the production of wine | |
YU57600A (en) | Bicyclic hydroxamic acid derivatives | |
AP1253A (en) | Pharmaceutical formulations comprising amoxocyllin and clavulanate. | |
AU2001290257A1 (en) | Glucopyranosyloxybenzylbenzene derivatives and medicinal compositions containing the same | |
AU2001290257A2 (en) | Glucopyranosyloxybenzylbenzene derivatives and medicinal compositions containing the same | |
WO2003054146A3 (en) | Self-assembly and mineralization of peptide-amphiphile nanofibers | |
WO2001044272A3 (en) | Daptomycin analogs as antibacterial agents | |
AU2001272925A1 (en) | Use of interleukin-4 antagonists and compositions thereof | |
EP1100522A4 (en) | Pulmonary delivery of active agents | |
AU7620200A (en) | Compositions and methods relating to the inhibition of casomorphin and gluteomorphin | |
ZA948669B (en) | New pyrazine carboxamide derivatives the preparation thereof and their use in pharmaceutical compositions | |
AU3227700A (en) | Skin sanitizing compositions | |
AU2001266152A1 (en) | Novel substituted nitrocatechols, their use in the treatment of some central andperipheral nervous system disorders and pharmaceutical compositions containing them | |
AU2001289606A1 (en) | Dry powder formulation comprising racecadotril | |
WO2001045650A3 (en) | Cosmetic use of the residues from wine production | |
TNSN04034A1 (en) | Combined preparations, containing 1,4-benzothiepine-1,1-dioxide derivatives and other active substances, and the use thereof | |
AU7027100A (en) | Novel compounds | |
SE0001916D0 (en) | Novel formulation | |
AU2002341555A1 (en) | Levothyroxine pharmaceutical compositions, methods of making and methods of administration | |
AU4929400A (en) | Pharmaceutical compositions for oral administration of phloroglucinol and preparation thereof | |
AU2001279193A1 (en) | Methods and compositions for the construction and use of viral envelops as display particles | |
WO2001022917A3 (en) | Effervescent compositions comprising nimesulide | |
ATE259213T1 (en) | ORAL CLEANSER | |
AU4543500A (en) | Pharmaceutical compositions and uses |